Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 263, pseudogene (RN7SL263P)

Target
RN7SL263P
Molecular classification
Other (pseudogene; non-coding RNA-derived pseudogene)
01

Overview

Most human 7SL RNA sequences found in the genome are pseudogenes, dispersed copies that result from retrotransposition or other molecular mechanisms, and are generally truncated, nonfunctional fragments of the authentic SRP RNA gene[1]. RN7SL263P specifically designates one such locus, with no demonstrable transcriptional activity or biological function. Mislabeling it with aliases such as "breakpoint cluster region protein" (BCR) or linking it to the BCR protein is incorrect, as BCR is a distinct protein-coding gene—a kinase involved in intracellular signaling and oncogenic fusion proteins—that bears no relation to 7SL RNA pseudogenes[2][6]. Only the true 7SL RNA gene encodes the scaffold RNA of the signal recognition particle, essential for cotranslational membrane protein targeting[3][7]. Pseudogenes like RN7SL263P have no current utility as drug targets, disease biomarkers, or functional RNAs.

Other names
RNA, 7SL, cytoplasmic 263, pseudogene
02

Mechanism of action

None; not drug-targetable.

03

Biological functions

None. 7SL RNA pseudogenes do not encode functional RNA or protein and thus serve no known direct biological function
04

Disease associations

None established for RN7SL263P. Functional 7SL RNA (in SRP) is implicated in protein targeting, but the pseudogenes themselves have no disease association
05

Safety considerations

None; not druggable or clinically relevant
06

Interacting drugs

None. No drugs interact with RN7SL263P, nor are there mechanisms of action for such interactions
07

Biomarkers

None; not applicable

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 263, pseudogene (RN7SL263P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 263, pseudogene (RN7SL263P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call